Geopolitical tensions
May impact local partnering and sales.
- Materiality
- high
Elekta B
Elekta is a global leader in radiotherapy solutions, specializing in advanced technologies to treat cancer and neurological diseases. The company is renowned for its innovative products like the Elekta Evo linear accelerator and the Elekta ONE software suite, which enhance treatment efficiency and patient outcomes. Elekta's offerings are supported by AI-driven services and a robust global network, making it a key player in the radiotherapy market. Headquartered in Stockholm, Sweden, Elekta operates across multiple regions, contributing to its strong market presence and financial performance.
4.5k
0.95
0.73
| % | |
|---|---|
| Linear Accelerators | 40% Includes Elekta Evo and other advanced radiotherapy equipment. |
| Software Solutions | 30% Comprises Elekta ONE and other software for treatment planning and management. |
| AI-supported Services | 15% AI-driven services to enhance treatment efficiency. |
| Specialty Products | 15% Includes niche radiotherapy products for specific treatments. |
Elekta serves a diverse range of customers primarily in the healthcare sector, including hospitals, cancer treatment...
- Hospitalsprimary
Purchase advanced radiotherapy equipment to enhance treatment capabilities.
- Cancer Treatment Centersprimary
Utilize Elekta's solutions for improved patient outcomes.
- Clinicssecondary
Adopt AI-supported services for operational efficiency.
Elekta operates globally with significant market presence in the Americas, EMEA, and APAC regions...
- •Strong market presence in Europe with new product launches
- •Growth in APAC markets despite challenges in China
- •Weaker sales in the U.S. due to market conditions
- •Strategic manufacturing and supply centers manage currency exposure
Elekta's strategic priorities focus on expanding its software offerings and enhancing its product portfolio with...
01
Expand software offeringsmedium-term
To enhance treatment planning and management capabilities.
02
Leverage AI technologieslong-term
To improve treatment efficiency and outcomes.
03
Global market expansionlong-term
To increase market share and reach new customers.
Elekta faces several risks, including geopolitical tensions that may affect its operations and partnerships in certain...
Regulatory risks
Impact product approvals and sales in the U.S.
- Materiality
- high
Currency fluctuations
Affect financial performance and cost management.
- Materiality
- medium
Revenue recognition
critical
Intangible asset impairment
high
: 11/08/2026